Literature DB >> 20690341

More allopurinol is needed to get gout patients < 0.36 mmol/l: a gout audit in the form of a before-after trial.

Bruce Arroll1, Merran Bennett, Nicola Dalbeth, Dilanka Hettiarachchi, Cribben Ben, Ginnie Shelling.   

Abstract

AIM: To establish a benchmark for gout control using the proportion of patients with serum uric acid (SUA) < 0.36 mmol/L, assess patients' understanding of their preventive medication and trial a mail and phone intervention to improve gout control.
METHODS: Patients clinically diagnosed with gout and baseline SUAs were identified in two South Auckland practices. A mail and phone intervention was introduced aimed at improving the control of gout. Intervention #1 took place in one practice over three months. Intervention #2 occurred in the other practice four to 16 months following baseline.
RESULTS: No significant change in SUA from intervention #1 after three months. The second intervention by mail and phone resulted in improvement in SUA levels with a greater proportion of those with SUA < 0.36 mmol/L and the difference in means statistically significant (p = 0.039 two-tailed paired t-test). Benchmarking for usual care was established at 38-43% SUA < 0.36 level. It was possible to increase from 38% to 50%. Issues relating to gout identified included lack of understanding of the need for long-term allopurinol and diagnosis and management for patients for whom English is not their first language. STRATEGIES FOR IMPROVEMENT: 1. Community workers who speak Pacific languages may assist GPs in communicating to non-English speaking patients. 2. Alternative diagnoses should be considered in symptomatic patients with prolonged normouricaemia. 3. GPs should gradually introduce allopurinol after acute gout attacks, emphasising importance of prophylaxis. 4. A campaign to inform patients about benefits of allopurinol should be considered. 5. A simple one keystroke audit is needed for gout audit and benchmarking. 6. GP guidelines for gout diagnosis and management should be available.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20690341

Source DB:  PubMed          Journal:  J Prim Health Care        ISSN: 1172-6156


  1 in total

1.  Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients.

Authors:  Carly A Janssen; Tim L Th A Jansen; Martijn A H Oude Voshaar; Harald E Vonkeman; Mart A F J van de Laar
Journal:  Rheumatol Int       Date:  2017-07-26       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.